Sources

5 Total Sources

Kalshi, Polymarket Draw Fire for FDA Drug Approval Bets as Critics Warn of Trial Manipulation

Left100%

Greater Baton Rouge Business Report7d ago

Prediction Markets Kalshi, Polymarket Face Criticism Over Drug Approval Wagering

The New York Times8d ago

Prediction Markets on Drug Trials and FDA Approvals Spark Concern

thebiointel.com8d ago

FDA Challenges Capricor's Phase 3 Results for DMD Cell Therapy: Industry Scrutiny Intensifies | BioIntel

Oncodaily9d ago

Kalshi is Betting on Trial Results and FDA Decisions Now, What's Next? - OncoDaily

Stocktwits8d ago

CAPR Stock On Track For Worst Day Ever — Analysts Divided On Deramiocel's Approval Probability After FDA Documents Paint 'Ugly Picture'